News

Octapharma improves people's health - and reduces the load on the grid

December 19, 2022
Octapharma's plant will soon start producing its first kWh. Photo: SBP
Octapharma's plant will soon start producing its first kWh. Photo: SBP
Octapharma is a leading company in pharmacology and works daily for human health. Now they are also contributing to society by strengthening the country's electricity grid with the help of a solar cell plant.

In Arlandastad, a few stone's throw away from the airport north of Stockholm, Octapharma's logistics center has been located since 2014. According to Johan Braunerhielm, project manager at SBP, there was a great desire internally at the pharmaceutical giant to run part of its operations on solar energy.
- "It is noticeable that the interest in green investments permeates the entire organization and then it is particularly fun in my role to deliver a plant," he says.

The project includes a 493 kW plant, which corresponds to almost 100 residential installations and is estimated to produce approximately 421,000 kilowatt hours per year.
- "The project has gone very well from start to finish, and I would like to attribute a large part of that to our relationships at Octapharma, which clearly show that they have top-class experience in the client role. For me, it is a pure pleasure to act in my role in collaboration with such a humble and solution-oriented customer, and who also has a consistent view of how the project is implemented in everything from sustainable guidelines to technology choices with a high level of safety in focus, says Johan Braunerhielm.

The company was founded in Switzerland in 1983 and has since grown to become a leading player in blood plasma and thus works to improve human health.
- There was a sense of security in how SBP presented and calculated the plant from the very first dialog. It gave me great confidence. Then I think the project was delivered exactly as promised from start to finish and all those who worked on the project from our side were satisfied with the implementation," says Mats Julin at Octapharma.

More green technology news

Back to News